½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1308050

¼¼°èÀÇ ½Å»ý¾Æ ¸ð´ÏÅ͸µ ½ÃÀå : ±â¼ú Çõ½Å°ú ¼ºÀå ±âȸ

Neonatal Monitoring: Technology Innovation and Growth Opportunities

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Frost & Sullivan | ÆäÀÌÁö Á¤º¸: ¿µ¹® 69 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½Ç½Ã°£ Çǵå¹é°ú Áö´ÉÀûÀÎ ÀÇ»ç °áÁ¤À» Á¦°øÇÏ´Â AI ´ëÀÀ ºñħ½ÀÀû ¸ð´ÏÅ͸µÀº Çõ½ÅÀûÀÎ ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù.

½Å»ý¾Æ ¸ð´ÏÅ͸µ(Neonatal Monitoring) ÀÇ·á ±â¼úÀº »ýÈÄ ¸çÄ¥ ¸î ÁÖ µ¿¾È ½Å»ý¾Æ °Ç°­°ú »ýü ½ÅÈ£¸¦ ¸ð´ÏÅ͸µÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ½Å»ý¾Æ ÁýÁß Ä¡·á½Ç(NICU), ±âŸ º´¿ø ¶Ç´Â °¡Á¤¿¡¼­ »ç¿ëµË´Ï´Ù. ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â ½Å»ý¾Æ °¨½Ã ÀåÄ¡¿¡´Â ½ÉÀüµµ(ECG) ¸ð´ÏÅÍ ÆÞ½º »ê¼Ò ÃøÁ¤±â, ¸ð´ÏÅÍ Ã¼¿Â, ¸ð´ÏÅÍ È£Èí ¸ð´ÏÅÍ µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº À¯¾Æ ȯ°æ ´Ù¾çÇÑ ÀÚ±ØÀ¸·Î ÀÎÇÑ °Ç°­ »óÅ º¯È­¸¦ ¸ð´ÏÅ͸µÇÏ°í ¹ß´Þ ÀÌÁ¤Ç¥¸¦ ÃßÀûÇÕ´Ï´Ù. ½Å»ý¾Æ »ý¸í°ú °Ç°­ »óŸ¦ ¸ð´ÏÅ͸µÇÏ¸é ½Å¼ÓÇÑ Ä¡·á°¡ ÇÊ¿äÇÑ °Ç°­ »óÅ Á¶±â ¹ß°ßÀ» °¡´ÉÇÏ°Ô ÇÏ¿© ÁßÁõ ½Å»ý¾Æ °Ç°­ »óÅÂ¿Í °æ°ú¸¦ ÃßÀûÇÏ¿© º´¿ø°ú °¡Á¤¿¡¼­ÀÇ ½Å»ý¾ÆÀÇ ¾ÈÀüÇÑ À̵¿À» º¸ÀåÇÏ´Â µ¥ Áß¿äÇÕ´Ï´Ù.

½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â¼úÀº Àúħ½À¼º, ħ½À¼º ¹× ºñħ½À¼ºÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÇöÀç ½Å»ý¾Æ ¸ð´ÏÅ͸µÀº Àúħ½À ±â¼ú »ç¿ëÀÌ Ç¥ÁØÀÌÁö¸¸, ¾÷°è´Â À¯¾Æ ÄèÀû¼º Çâ»ó°ú °¨¿° ¸®½ºÅ© Àú°¨, ºÎ¸ð Á¤½ÅÀû ½ºÆ®·¹½º °æ°¨, Çコ Äɾî Àü¹®°¡ »ç¿ë ¿ëÀÌÇÔ µî ¸î °¡Áö ÀåÁ¡À» Á¦°øÇÏ´Â ºñħ½À ±â¼ú·Î ÀüȯµÇ°í ÀÖ½À´Ï´Ù.

ÀÌ Frost& Sullivan ¿¬±¸´Â ´Ù¾çÇÑ ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â¼ú¿¡ ÁßÁ¡À» µÓ´Ï´Ù. ½Å»ý¾Æ ¸ð´ÏÅ͸µ ¼ö¿ä°¡ ³ôÀº ¿þ¾î·¯ºí ±â±â¿Í ºñÁ¢ÃËÇü ±â±â µî ÁÖ¿ä ºñħ½À¼º ±â±â¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø ¹× ¾ïÁ¦ ¿äÀÎÀ» °ËÁõÇÕ´Ï´Ù.

¶ÇÇÑ ÃæÁ·µÇÁö ¾ÊÀº ½ÃÀå ¿ä±¸, ÁÖ¿ä ¸ð´ÏÅ͸µ ¼ö´Ü, ¿þ¾î·¯ºí ¹× ºñÁ¢ÃË½Ä ÀåÄ¡ »ç·Ê, ½Å±â¼ú ¹× »õ·Î¿î ÀåÄ¡ Æò°¡ ¸Å°³º¯¼ö¸¦ Æò°¡ÇÕ´Ï´Ù.

½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â±â ÀÓ»ó½ÃÇè ºÐ¼®, Á¤Ä¡, °æÁ¦, »çȸ, ±â¼ú(PEST) ºÐ¼®, °í°´ ¿©Á¤ ¸ÅÇÎ, ¹Ì·¡ ±â¼ú Àü¸Á, ƯÇã Á¤¼¼¿¡µµ ÁÖ¸ñÇÏ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½ÃÀå ÁøÃâ±â¾÷ Áß¿ä ¼ºÀå ±âȸµµ ¹àÇôÁö°í ÀÖ½À´Ï´Ù.

ÀÌ ¼³¹®Á¶»ç°¡ ´äº¯ÇÏ´Â ÁÖ¿ä Áú¹®:

  • ½ÃÀå ÁÖ¿ä ¹ÌÃæÁ· ¿ä±¸´Â ¹«¾ùÀΰ¡
  • ÁÖ¿ä ¸ð´ÏÅ͸µ ¼ö´ÜÀº ¹«¾ùÀԴϱî, ½Å»ý¾Æ ¸ð´ÏÅ͸µÀº ¿Ö Áß¿äÇÑ°¡
  • ½ÃÀå ¼ºÀå ÃËÁø ¿äÀΰú ¾ïÁ¦ ¿äÀÎÀº ¹«¾ùÀΰ¡
  • ºñħ½ÀÀû ¿þ¾î·¯ºí ±â±â¶õ, ÀÌ ºÐ¾ß ´ëµÎµÇ°í ÀÖ´Â ±â¼úÀº
  • ºñÁ¢ÃËÇü ÀåÄ¡¶õ, ÀÌ ºÐ¾ßÀÇ ´ëµÎµÇ°í ÀÖ´Â ±â¼úÀº
  • ½Å»ý¾Æ ¸ð´ÏÅ͸µ ÀåÄ¡ ÀÓ»ó½ÃÇè ºÐ¼®ÀÇ ÁÖ¿ä ¿ä¾àÀº ¹«¾ùÀΰ¡
  • PEST ºÐ¼®, °í°´ ¿©Á¤ ¸ÅÇÎ, ¹Ì·¡ ±â¼ú ·Îµå¸ÊÀº ¹«¾ùÀΰ¡
  • ƯÇã¿Í Á¤¼¼´Â ¾î¶°ÇÑ°¡
  • ½Å»ý¾Æ ¸ð´ÏÅ͸µ ºÐ¾ß ±â¼ú °³¹ßÀÚÀÇ ¼ºÀå ±âȸ´Â ¾î¶°ÇÑ°¡

¸ñÂ÷

Àü·« °úÁ¦

  • ¿Ö ¼ºÀåÀÌ ¾î·Á¿öÁö°í Àִ°¡ The Strategic Imperative 8(TM) : ¼ºÀåÀ» ¸·´Â ¿äÀÎ
  • The Strategic Imperative 8(TM)
  • ½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â¼ú ¾÷°è Àü·« Áß¿ä»çÇ× : »óÀ§ 3°³ Ç׸ñ ¿µÇâ
  • ¼ºÀå ±âȸ Growth Pipeline Engine(TM) ÃËÁø
  • Á¶»ç ¹æ¹ý

¼ºÀå ±âȸ ºÐ¼®

  • ºÐ¼® ¹üÀ§
  • ÁÖ¿ä ¹ÌÃæÁ· ¿ä±¸ : ½Å»ý¾Æ »ç¸Á·ü °ü·Ã
  • ±âŸ ¾ð¸ä ¿ä±¸¿Í ½Å»ý¾Æ ¸ð´ÏÅ͸µ Á߿伺
  • ºÐ¸¸½Ç ½Å»ý¾Æ ¸ð´ÏÅ͸µ Á߿伺
  • ½Å»ý¾Æ ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ±â±â À¯Çü
  • ½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â±â ºÎ¹®È­
  • ½Å»ý¾Æ ¸ð´ÏÅ͸µ ÁÖ¿ä Ä¡·á ºÐ¾ß
  • ¼ºÀå ÃËÁø ¿äÀÎ
  • ¼ºÀå ¾ïÁ¦ ¿äÀÎ

ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ : ¿þ¾î·¯ºí ±â±â

  • ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ¿þ¾î·¯ºí ±â±â : °³·«
  • ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ¿þ¾î·¯ºí ±â±â : SWOT ºÐ¼®
  • ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ¿þ¾î·¯ºí ±â±â : ÁÖ¿ä »ç·Ê, B2B
  • ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ¿þ¾î·¯ºí ±â±â : ÁÖ¿ä »ç·Ê, B2B/B2C
  • ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ¿þ¾î·¯ºí ±â±â : ÁÖ¿ä »ç·Ê, B2C
  • »õ·Î¿î ºñħ½À¼º ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ¿þ¾î·¯ºí ±â±â
  • ½Å±â¼ú : °¢Á¾ ¿ëµµ AI
  • ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ½Å±Ô ¿þ¾î·¯ºí ±â±â Æò°¡ ÆĶó¹ÌÅÍ

ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ : ºñÁ¢ÃË½Ä ÀåÄ¡

  • ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µÀ» À§ÇÑ ºñÁ¢ÃËÇü ±â±â : ¼Ò°³
  • ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ºñÁ¢ÃËÇü ±â±â : SWOT ºÐ¼®
  • ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ºñÁ¢ÃËÇü ±â±â : ÁÖ¿ä »ç·Ê, B2B
  • ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ºñÁ¢ÃËÇü ±â±â : ÁÖ¿ä »ç·Ê, B2B/B2C
  • ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ºñÁ¢ÃËÇü ±â±â : ÁÖ¿ä »ç·Ê, B2C
  • ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ºñÁ¢ÃËÇü ±â±â : ½Å±Ô ±â¼ú
  • ½Å±â¼ú : °¢Á¾ ¿ëµµ AI
  • ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ºñÁ¢ÃËÇü ±â±â Æò°¡ ÆĶó¹ÌÅÍ

¾÷°è Æò°¡ ¹× ºÐ¼®

  • ½Å»ý¾Æ ¸ð´ÏÅ͸µ¿ë ¿þ¾î·¯ºí ±â±â¿Í ºñÁ¢ÃËÇü ±â±â:ºñ±³
  • ÀÓ»ó °³¹ß Áß ½Å»ý¾Æ ¸ð´ÏÅ͸µ ÀåÄ¡ Àüü(ºñ Á¾ÇÕÀû)
  • ½ÃÀå °³Ã´À» À§ÇÑ ±â±â Á¦Á¶¾÷ü PEST ºÐ¼®
  • °í°´ ¿©Á¤, ¸ÊÇÎ
  • ¹Ì·¡ ±â¼ú Àü¸Á

ƯÇã »óȲ

  • ½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â¼ú ƯÇã »óȲ
  • »óÀ§ ƯÇã ¾ç¼öÀÎ
  • ÁÖ¿ä ƯÇã

¼ºÀå ±âȸ À¯´Ï¹ö½º

  • ¼ºÀå ±âȸ 1 : Áõ°Å ±â¹Ý ±ÔÁ¦ ½ÂÀÎ
  • ¼ºÀå ±âȸ 2 : ºñÁ¢ÃË ±â±â Á¤¹Ðµµ¸¦ Çâ»ó½ÃÅ°´Â ½ÅÈ£ ó¸® ±â¼ú°ú AI ¾Ë°í¸®Áò
  • ¼ºÀå ±âȸ 3 : ºí·Ï üÀÎ ±â¼ú ½Å»ý¾Æ ¸ð´ÏÅ͸µ µ¥ÀÌÅÍ º¸¾È ¹× °³ÀÎ Á¤º¸ º¸È£ °­È­

ºÎ·Ï

  • ±â¼ú Áغñ ·¹º§(TRL) : Çؼ³

´ÙÀ½ ´Ü°è

  • ´ÙÀ½ ´Ü°è
  • ¿Ö Frost& SullivanÀΰ¡
  • ¸éÃ¥»çÇ×
NJH 23.08.21

AI-enabled Noninvasive Monitoring that Offers Real-time Feedback and Intelligent Decision-making Drives Transformational Growth.

Neonatal monitoring medical technologies monitor newborn babies' health and vital signs in the first few days or weeks of their life. These technologies are used in neonatal intensive care units (NICUs) and other hospital settings or at home. Some commonly used neonatal monitoring devices include electrocardiography (ECG) monitors, pulse oximetry monitors, temperature monitors, and respiratory monitors. Such technologies monitor health changes caused by various stimuli in a baby's environment and track development milestones. Monitoring a newborn's vitals and health is important as it enables early detection of health conditions that require immediate medical attention; tracks critically ill infants' health and progress; and ensures the safe transition of the newborn from hospital to home.

Neonatal monitoring technologies can be minimally invasive, invasive, and noninvasive. Though the current standard for neonatal monitoring is to use minimally invasive technologies, the industry is shifting to noninvasive technologies that offer several benefits, including increased comfort and reduced infection risk for the baby, less emotional stress for the parents, and ease of use for healthcare professionals.

This Frost & Sullivan study highlights different noninvasive neonatal monitoring technologies. It focuses on key noninvasive devices, including wearable and contactless devices in high demand for neonatal monitoring.

The study examines factors that drive and restrain market growth.

It also evaluates unmet market needs, key monitoring measures, examples of wearable and contactless devices, emerging technologies, and evaluation parameters for a novel device.

The study highlights the clinical trial analysis of neonatal monitoring devices; political, economic, social, and technological (PEST) analysis; customer journey mapping; future technology outlook; and patent landscape. In addition, it identifies significant growth opportunities for market participants.

Key Questions This Study Answers:

  • What is the market's key unmet need?
  • What are the key monitoring measures? Why is neonatal monitoring important?
  • Which factors drive and restrain market growth?
  • What are noninvasive wearable devices? Which technologies are emerging in this space?
  • What are contactless devices? Which technologies are emerging in this space?
  • What does the neonatal monitoring devices clinical trial analysis landscape look like?
  • What does the PEST analysis, customer journey mapping, and future technology roadmap look like?
  • What does the patent landscape look like?
  • What are the growth opportunities for technology developers in the neonatal monitoring space?

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Neonatal Monitoring Technology Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™
  • Research Methodology

Growth Opportunity Analysis

  • Scope of Analysis
  • Key Unmet Need: Concerning Newborn Mortality Rates
  • Other Unmet Needs and the Importance of Neonatal Monitoring
  • Importance of Key Monitoring Measures for Newborns in Delivery Rooms
  • Device Types Enabling Neonatal Monitoring
  • Neonatal Monitoring Device Segmentation
  • Neonatal Monitoring Key Therapy Areas
  • Growth Drivers
  • Growth Restraints

Noninvasive Neonatal Monitoring, Wearable Devices

  • Noninvasive Neonatal Monitoring Wearable Devices: Introduction
  • Noninvasive Neonatal Monitoring Wearable Devices: SWOT Analysis
  • Noninvasive Neonatal Monitoring Wearable Devices: Key Examples, B2B
  • Noninvasive Neonatal Monitoring Wearable Devices: Key Examples, B2B/B2C
  • Noninvasive Neonatal Monitoring Wearable Devices: Key Examples, B2C
  • Emerging Noninvasive Neonatal Monitoring Wearable Devices
  • Emerging Technologies: AI in Different Applications
  • Evaluation Parameters for Novel Wearable Devices for Neonatal Monitoring

Noninvasive Neonatal Monitoring, Contactless Devices

  • Noninvasive Neonatal Monitoring Contactless Devices: Introduction
  • Noninvasive Neonatal Monitoring Contactless Devices: SWOT Analysis
  • Noninvasive Neonatal Monitoring Contactless Devices: Key Examples, B2B
  • Noninvasive Neonatal Monitoring Contactless Devices: Key Examples, B2B/B2C
  • Noninvasive Neonatal Monitoring Contactless Devices: Key Examples, B2C
  • Noninvasive Neonatal Monitoring Contactless Devices: Emerging Technologies
  • Emerging Technologies: AI in Different Applications
  • Evaluation Parameters for Novel Contactless Devices for Neonatal Monitoring

Industry Assessment and Analysis

  • Neonatal Monitoring Wearable and Contactless Devices: A Comparison
  • Neonatal Monitoring Devices in Clinical Development, Overall (nonexhaustive)
  • PEST Analysis for Device Manufacturers to Develop Market Strategies
  • Customer Journey Mapping
  • Future Technology Outlook

Patent Landscape

  • Neonatal Monitoring Technologies: Patent Landscape
  • Top Patent Assignees
  • Key Patents

Growth Opportunity Universe

  • Growth Opportunity 1: Evidence-based Regulatory Approval
  • Growth Opportunity 2: Signal-processing Techniques and AI Algorithms to Improve Contactless Devices' Accuracy
  • Growth Opportunity 3: Enhancing Neonatal Monitoring Data Security and Privacy through Blockchain Technology

Appendix

  • Technology Readiness Level (TRL): Explanation

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • Legal Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦